Dr. John G. Flanagan Joins Zilia’s Scientific Advisory Board
Zilia is honored to welcome current Dean and Professor at the University of California Berkeley School of Optometry Dr. John G. Flanagan on our Scientific Advisory Board.
Dr. Flanagan is an internationally recognized researcher with extensive expertise ranging from ocular imaging to ocular blood flow and vascular reactivity.
“We are incredibly honored to have Dr. Flanagan join our team of scientific advisors,” said Patrick Sauvageau, chief executive officer at Zilia. Dr. Flanagan’s vast expertise in the pathophysiology of ocular diseases will be of great value to our team as we realize our goal of revolutionizing the early diagnosis and management of ocular diseases by quantifying key ocular biomarkers such as oxygen saturation. We are absolutely thrilled to have Dr. Flanagan onboard.”
Dr. Flanagan graduated in Optometry and Vision Sciences from Aston University, Birmingham, UK in 1980, where he later earned his PhD in 1985. During his career, he has received a multitude of honors for his work including the Certificate of Merit for Research Excellence (Glaucoma Research Society of Canada), the Glenn A Fry Award (American Academy of Optometry), and more recently, the President’s Award for services to the profession of optometry (American Optometric Association). He has supervised 45 graduate students and has authored over 175 peer-reviewed publications. In addition, he has 14 book chapters, 3 books and has given numerous invited lectures to both professional and academic audiences around the world.
“Dr. Flanagan’s vast expertise in the pathophysiology of ocular diseases will be of great value to our team as we realize our goal of revolutionizing the early diagnosis and management of ocular diseases.”
Patrick Sauvageau, Zilia’s CEO
About the Scientific Advisory Board
Zilia’s Scientific Advisory Board is composed of independent external advisors who contribute expert advice on Zilia’s product development and guidance towards new clinical applications. Such scientific and technological knowledge helps Zilia make conscious and fact-based decisions in a complex and changing environment.
Dr. Flanagan joins a group which currently includes the following members:
Dr. Rajat N Agrawal, President and CEO of Retina Global
Dr. Ike Ahmed, Assistant Professor, University of Toronto
To learn more about Zilia’s Scientific Advisory Board members, please visit our About Us page.
Written by the Zilia team on April 17, 2020
The eye is a marvelous and mysterious organ and we are constantly making discoveries when it comes to its...
Nearly 4.2 million Americans aged 40 and older suffer from uncorrectable vision impairment (1). As the...
At the third annual general meeting of Optonique, which was held virtually on June 11, Zilia’s CEO, Dr....